25 February 2021 - - US-based contract research, development and manufacturing solutions provider Albany Molecular Research, Inc has been chosen to support the development and manufacture of lipid excipients for the Pfizer-BioNTech COVID-19 vaccine, the company said.

For the past several months, AMRI has been providing development, scale-up and manufacturing services at a number of its global R and D and production sites, demonstrating operational flexibility and expertise to deliver capacity for lipid excipient supply for the vaccine at unprecedented speed to support the program.

This critical lipid excipient surrounds and protects the vaccine's active ingredient.

AMRI, a contract research development and manufacturing organization, partners with the pharmaceutical and biotechnology industries.

AMRI's team provides a suite of solutions in discovery, development, analytical services, and API and drug product manufacturing.